The evolution of polymer based nanoparticles as a drug delivery carrier via pharmaceutical nano/microencapsulation has greatly promoted the development of nano- and micro-medicine in the past few decades. Poly(lactide-co-glycolide) (PLGA) and chitosan, which are biodegradable and biocompatible polymers, have been approved by both the Food & Drug Administration (FDA) and European Medicine Agency (EMA), making them ideal biomaterials that can be advanced from laboratory development to clinical oral and parental administrations. PLGA and chitosan encapsulated nanoparticles (NPs) have successfully been developed as new oral drug delivery systems with demonstrated high efficacy. This review aims to provide a comprehensive overview of the fabrication of PLGA and chitosan particulate systems using nano/microencapsulation methods, the current progress and the future outlooks of the nanoparticulate drug delivery systems. Especially, we focus on the formulations and nano/micro-encapsulation techniques using top-down techniques. It also addresses how the different phases including the organic and aqueous ones in the emulsion system interact with each other and subsequently influence the properties of the drug delivery system. Besides, surface modification strategies which can effectively engineer intrinsic physicochemical properties are summarised. Finally, future perspectives and potential directions of PLGA and chitosan nano/microencapsulated drug systems are outlined.

A new type of polyamide thin-film composite forward osmosis (FO) membranes were prepared by controlling dopamine self-polymerization in the aqueous phase during interfacial polymerization. The as-prepared membranes were investigated by attenuated total reflection Fourier transform infrared, X-ray photoelectron spectroscopy, field-emission scanning electron microscopy, atomic force microscopy and water contact angle measurements. The influence of the dopamine self-polymerization degree with different polydopamine particle sizes on membrane morphologies and chemical properties was studied by regulating dopamine concentrations in the aqueous phase. FO performance of the membrane was evaluated under two different modes, i.e. active layer facing draw solution (AL-DS) and active layer facing feed solution (AL-FS). The optimized FO membranes achieved a doubly enhanced water flux (22.08 L m⁻² h⁻¹) compared with the control membrane without dopamine incorporation, and a half-reduced reverse salt flux (32.77 mmol m⁻² h⁻¹) with deionized water as the feed and 1 M NaCl as the draw in the AL-FS mode. The optimized FO membrane showed a significantly reduced structural parameter (176 μm) compared with the control membrane (635 μm), indicating the minimised internal concentration polarization. Moreover, the new FO membranes had less flux decline than the control membrane, suggesting the improved antifouling performance of the membrane. Incorporation of dopamine during interfacial polymerization can be an effective strategy to fabricate high-performance FO membranes with excellent antifouling properties.